ask="6.43"
ask_size="400"
average_daily_volume="880594"
bid="6.26"
bid_size="1000"
book_value="0.05"
change="-0.79"
change_from_200_day_moving_average="1.78"
change_from_50_day_moving_average="0.26"
change_from_52_week_high="-2.93"
change_From_52_week_low="4.71"
change_in_percent="-11.08%"
close="6.34"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-57.26M"
eps_estimate_current_year="-0.91"
eps_estimate_next_quarter="-0.22"
eps_estimate_next_year="-0.83"
ex_dividend_date="N/A"
float_shares="46288000"
high="7.30"
high_52_weeks="9.27"
last_trade_date="1/9/2017"
last_trade_price="6.34"
last_trade_size="56284"
last_trade_time="4:00pm"
low="6.27"
low_52_weeks="1.63"
market_capitalization="467.63M"
moving_average_200_day="4.56"
moving_average_50_day="6.08"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.08"
open="7.26"
pe_ratio="N/A"
peg_ratio="-0.38"
percent_change_from_200_day_moving_average="+39.15%"
percent_change_from_50_day_moving_average="+4.26%"
percent_change_from_52_week_high="-31.61%"
percent_change_from_52_week_low="+288.96%"
previous_close="7.13"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="132.04"
price_per_sales="23.93"
revenue="21.97M"
shares_outstanding="73758000"
short_ratio="13.23"
stock_exchange="NMS"
symbol="BCRX"
volume="1943392"
weeks_range_52="1.63 - 9.27"
